# Axillary Reverse Mapping

> **NCT01381315** · PHASE2 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 210 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Injection of isotope
- **PROCEDURE:** Axillary lymph node dissection

## Key facts

- **NCT ID:** NCT01381315
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381315, "Axillary Reverse Mapping". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01381315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*